T. Rowe Price Associates’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $33K | Sell |
|
|||||
|
2024
Q4 | $55K | Hold |
|
|||||
|
2024
Q3 | $98K | Sell |
|
|||||
|
2024
Q2 | $164K | Buy |
|
|||||
|
2024
Q1 | $239K | Buy |
|
|||||
|
2023
Q4 | $100K | Buy |
|
|||||
|
2023
Q3 | $101K | Hold |
|
|||||
|
2023
Q2 | $121K | Sell |
|
|||||
|
2023
Q1 | $134K | Hold |
|
|||||
|
2022
Q4 | $104K | Hold |
|
|||||
|
2022
Q3 | $101K | Buy |
|
|||||
|
2022
Q2 | $114K | Buy |
|
|||||
|
2022
Q1 | $94K | Buy |
|
|||||
|
2021
Q4 | $143K | Sell |
|
|||||
|
2021
Q3 | $292K | Buy |
|
|||||
|
2021
Q2 | $153K | Buy |
|
|||||
|
2021
Q1 | $103K | Buy |
|